Latest filing published 24 Feb 2026 for ImmunityBio, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David C. Sachs: trading record in brief
David C. Sachs is a declared insider of ImmunityBio, Inc. (finance chief), with filings sourced from SEC (Form 4). The record holds 18 filings, for trades running from 9 September 2021 to 22 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 24 February 2026, reports a share grant of €153k in ImmunityBio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David C. Sachs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,650 shares0Common StockSEC:0001848899-26-000005:0
- 82,236 shares0Common StockSEC:0001848899-26-000003:0
- 30,397 shares0Common StockSEC:0001848899-26-000001:0
- 40,650 shares0Common StockSEC:0001326110-25-000022:0
- 30,397 shares0Common StockSEC:0001326110-25-000003:0
- 70,745 shares0Common StockSEC:0001326110-24-000014:0
- 30,397 shares0Common StockSEC:0001326110-24-000008:0
- 70,744 shares0Common StockSEC:0001326110-23-000115:0
- 7,598 shares0Common StockSEC:0001326110-23-000005:0
- 17,242 shares0Common StockSEC:0001326110-21-000012:0
- 7,598 shares0Common StockSEC:0001209191-21-055786:0
11 of 11 declarations
